Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2021
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+23.1%
|
-
|
|
Apr 22
2021
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+3.05%
|
-
|
|
Apr 22
2021
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+5.03%
|
-
|
|
Apr 22
2021
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+50.0%
|
-
|
|
Apr 22
2021
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
255
+6.41%
|
-
|
|
Mar 02
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
215
-45.94%
|
$163,400
$760.0 P/Share
|
|
Mar 02
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
379
-80.13%
|
$288,040
$760.0 P/Share
|
|
Feb 28
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-8.76%
|
-
|
|
Feb 28
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
725
+18.18%
|
-
|
|
Feb 28
2021
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-1.28%
|
-
|
|
Feb 28
2021
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
752
+2.52%
|
-
|
|
Feb 28
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
187
-3.72%
|
-
|
|
Feb 28
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
376
+6.95%
|
-
|
|
Feb 28
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-30.36%
|
-
|
|
Feb 28
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
419
+38.41%
|
-
|
|
Feb 28
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-3.52%
|
-
|
|
Feb 28
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
752
+6.63%
|
-
|
|
Feb 28
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-44.09%
|
-
|
|
Feb 28
2021
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
752
+47.06%
|
-
|
|
Feb 28
2021
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-9.67%
|
-
|
|
Feb 28
2021
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,289
+16.3%
|
-
|
|
Feb 17
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
655
-72.14%
|
$512,210
$782.0 P/Share
|
|
Feb 17
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
2,958
-53.81%
|
$2,313,156
$782.0 P/Share
|
|
Feb 17
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,485
-94.05%
|
$1,161,270
$782.0 P/Share
|
|
Feb 15
2021
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,315
-14.45%
|
-
|
|
Feb 15
2021
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,667
+22.26%
|
-
|
|
Feb 15
2021
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-1.7%
|
-
|
|
Feb 15
2021
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,292
+3.72%
|
-
|
|
Feb 15
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
827
-5.93%
|
-
|
|
Feb 15
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,768
+11.25%
|
-
|
|
Feb 15
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Payment of exercise price or tax liability
|
Direct |
348
-15.53%
|
-
|
|
Feb 15
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
1,003
+30.88%
|
-
|
|
Feb 15
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-6.69%
|
-
|
|
Feb 15
2021
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,166
+16.96%
|
-
|
|
Feb 15
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
3,791
+8.42%
|
$163,013
$43.11 P/Share
|
|
Feb 15
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,262
-4.26%
|
-
|
|
Feb 15
2021
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,097
-27.21%
|
-
|
|
Feb 15
2021
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,582
+36.96%
|
-
|
|
Feb 11
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
12,487
-59.33%
|
$9,989,600
$800.0 P/Share
|
|
Feb 11
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+49.94%
|
$3,528,000
$168.41 P/Share
|
|
Feb 02
2021
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
11,020
-78.71%
|
$8,397,240
$762.14 P/Share
|
|
Feb 02
2021
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+50.0%
|
$2,352,000
$168.41 P/Share
|
|
Jan 29
2021
|
Marshall Mohr Executive VP Global Business S |
SELL
Open market or private sale
|
Direct |
9,375
-99.49%
|
$7,040,625
$751.66 P/Share
|
|
Jan 29
2021
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+49.87%
|
$1,387,500
$148.03 P/Share
|
|
Jan 26
2021
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,500
-24.18%
|
$1,885,000
$754.48 P/Share
|
|
Jan 26
2021
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+19.47%
|
$402,500
$161.27 P/Share
|
|
Jan 26
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
SELL
Open market or private sale
|
Direct |
1,652
-16.69%
|
$1,245,608
$754.48 P/Share
|
|
Jan 26
2021
|
Reiter Kara Andersen Sr VP General Counsel & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+19.03%
|
$212,500
$170.76 P/Share
|
|
Jan 26
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
521
-25.41%
|
$392,834
$754.48 P/Share
|
|
Jan 26
2021
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+19.83%
|
$229,761
$441.58 P/Share
|